

Revolution Medicines (NASDAQ:RVMD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Revolution Medicines (NASDAQ:RVMD) through any online brokerage.
Other companies in Revolution Medicines’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Revolution Medicines has a consensus price target of $202.07.
The stock price for Revolution Medicines (NASDAQ: RVMD) is $217 last updated November 5, 2026 at 6:49 AM EST.
There are no upcoming dividends for Revolution Medicines.
Revolution Medicines does not have any upcoming earnings scheduled.
There is no upcoming split for Revolution Medicines.
Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer...